| pubmed-article:6354254 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6354254 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:6354254 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:6354254 | lifeskim:mentions | umls-concept:C0020663 | lld:lifeskim |
| pubmed-article:6354254 | lifeskim:mentions | umls-concept:C0010132 | lld:lifeskim |
| pubmed-article:6354254 | lifeskim:mentions | umls-concept:C0028752 | lld:lifeskim |
| pubmed-article:6354254 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:6354254 | lifeskim:mentions | umls-concept:C0162801 | lld:lifeskim |
| pubmed-article:6354254 | pubmed:issue | 18 | lld:pubmed |
| pubmed-article:6354254 | pubmed:dateCreated | 1983-12-17 | lld:pubmed |
| pubmed-article:6354254 | pubmed:abstractText | Sequence analysis was performed on a 41-residue polypeptide that has been identified as the predominant form of high intrinsic corticotropin-releasing activity of rat hypothalamus. The sequence of residues 1-39 of this corticotropin-releasing factor (CRF) was determined by Edman degradation of a partially purified peptide in a highly sensitive spinning cup sequencer after selective blocking of CRF or its main contaminant with o-phthalaldehyde. This approach was validated by peptide mapping of CRF of a highly purified preparation. Peptide mapping was accomplished with reverse-phase high-pressure liquid chromatography of CRF fragments obtained by digestion with clostripain. The identities of the fragments cleaved from CRF were established by chromatographic comparison with synthetic peptides, amino acid analysis, and Edman degradation. On the basis of these experiments, the primary structure of rat hypothalamic CRF was established to be H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu- Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn - Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2. It is expected that the o-phthalaldehyde strategy will facilitate the sequence analysis of partially purified peptides containing proline residues. | lld:pubmed |
| pubmed-article:6354254 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6354254 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6354254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6354254 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6354254 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6354254 | pubmed:issn | 0006-2960 | lld:pubmed |
| pubmed-article:6354254 | pubmed:author | pubmed-author:ValuGG | lld:pubmed |
| pubmed-article:6354254 | pubmed:author | pubmed-author:RivierJJ | lld:pubmed |
| pubmed-article:6354254 | pubmed:author | pubmed-author:SpiessJJ | lld:pubmed |
| pubmed-article:6354254 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6354254 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:6354254 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:6354254 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6354254 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6354254 | pubmed:pagination | 4341-6 | lld:pubmed |
| pubmed-article:6354254 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:meshHeading | pubmed-meshheading:6354254-... | lld:pubmed |
| pubmed-article:6354254 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6354254 | pubmed:articleTitle | Sequence analysis of rat hypothalamic corticotropin-releasing factor with the o-phthalaldehyde strategy. | lld:pubmed |
| pubmed-article:6354254 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6354254 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6354254 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6354254 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6354254 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6354254 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6354254 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6354254 | lld:pubmed |
